250 related articles for article (PubMed ID: 21832164)
1. CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma.
Qian J; Yi H; Guo C; Yu X; Zuo D; Chen X; Kane JM; Repasky EA; Subjeck JR; Wang XY
J Immunol; 2011 Sep; 187(6):2905-14. PubMed ID: 21832164
[TBL] [Abstract][Full Text] [Related]
2. Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.
Yi H; Guo C; Yu X; Gao P; Qian J; Zuo D; Manjili MH; Fisher PB; Subjeck JR; Wang XY
Cancer Res; 2011 Nov; 71(21):6611-20. PubMed ID: 21914786
[TBL] [Abstract][Full Text] [Related]
3. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.
Wang XY; Chen X; Manjili MH; Repasky E; Henderson R; Subjeck JR
Cancer Res; 2003 May; 63(10):2553-60. PubMed ID: 12750279
[TBL] [Abstract][Full Text] [Related]
4. Absence of scavenger receptor A promotes dendritic cell-mediated cross-presentation of cell-associated antigen and antitumor immune response.
Guo C; Yi H; Yu X; Hu F; Zuo D; Subjeck JR; Wang XY
Immunol Cell Biol; 2012 Jan; 90(1):101-8. PubMed ID: 21383767
[TBL] [Abstract][Full Text] [Related]
5. Suppression of antigen-specific CD4+ T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell.
Yi H; Zuo D; Yu X; Hu F; Manjili MH; Chen Z; Subjeck JR; Wang XY
J Mol Med (Berl); 2012 Apr; 90(4):413-26. PubMed ID: 22083206
[TBL] [Abstract][Full Text] [Related]
6. Pattern recognition scavenger receptor SRA/CD204 down-regulates Toll-like receptor 4 signaling-dependent CD8 T-cell activation.
Yi H; Yu X; Gao P; Wang Y; Baek SH; Chen X; Kim HL; Subjeck JR; Wang XY
Blood; 2009 Jun; 113(23):5819-28. PubMed ID: 19349620
[TBL] [Abstract][Full Text] [Related]
7. SRA inhibition improves antitumor potency of antigen-targeted chaperone vaccine.
Qian J; Yu X; Liu Z; Cai J; Manjili MH; Yang H; Guo C; Wang XY
Front Immunol; 2023; 14():1118781. PubMed ID: 36793731
[TBL] [Abstract][Full Text] [Related]
8. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.
Wang XY; Sun X; Chen X; Facciponte J; Repasky EA; Kane J; Subjeck JR
J Immunol; 2010 Jun; 184(11):6309-19. PubMed ID: 20439916
[TBL] [Abstract][Full Text] [Related]
9. Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I.
Facciponte JG; Wang XY; Subjeck JR
Eur J Immunol; 2007 Aug; 37(8):2268-79. PubMed ID: 17615582
[TBL] [Abstract][Full Text] [Related]
10. In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer.
Guo C; Yi H; Yu X; Zuo D; Qian J; Yang G; Foster BA; Subjeck JR; Sun X; Mikkelsen RB; Fisher PB; Wang XY
Mol Cancer Ther; 2012 Nov; 11(11):2331-41. PubMed ID: 22896667
[TBL] [Abstract][Full Text] [Related]
11. Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination.
Wang H; Yu X; Guo C; Zuo D; Fisher PB; Subjeck JR; Wang XY
J Immunol; 2013 Dec; 191(12):6010-21. PubMed ID: 24218449
[TBL] [Abstract][Full Text] [Related]
12. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
[TBL] [Abstract][Full Text] [Related]
13. A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.
Yu X; Guo C; Yi H; Qian J; Fisher PB; Subjeck JR; Wang XY
Cancer Res; 2013 Apr; 73(7):2093-103. PubMed ID: 23333935
[TBL] [Abstract][Full Text] [Related]
14. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity.
Wang XY; Kazim L; Repasky EA; Subjeck JR
J Immunol; 2001 Jan; 166(1):490-7. PubMed ID: 11123328
[TBL] [Abstract][Full Text] [Related]
15. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
16. Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy.
Guo C; Subjeck JR; Wang XY
Methods Mol Biol; 2018; 1709():345-357. PubMed ID: 29177671
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patients.
Wach MM; Subjeck JR; Wang XY; Repasky E; Matsuzaki J; Yu H; Wang C; Fisher D; Skitzki JJ; Kane JM
Melanoma Res; 2022 Apr; 32(2):88-97. PubMed ID: 35254331
[TBL] [Abstract][Full Text] [Related]
18. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.
Manjili MH; Henderson R; Wang XY; Chen X; Li Y; Repasky E; Kazim L; Subjeck JR
Cancer Res; 2002 Mar; 62(6):1737-42. PubMed ID: 11912148
[TBL] [Abstract][Full Text] [Related]
19. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
[TBL] [Abstract][Full Text] [Related]
20. Scavenger receptor-A negatively regulates antitumor immunity.
Wang XY; Facciponte J; Chen X; Subjeck JR; Repasky EA
Cancer Res; 2007 May; 67(10):4996-5002. PubMed ID: 17510431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
